New oligopeptide immunoglobulin G test for human parvovirus B19 antibodies.
AUTOR(ES)
Schwarz, T F
RESUMO
A new, highly sensitive and specific enzyme immunoassay using oligopeptides as antigen (enzyme-linked immunosorbent assay [ELISA] B19-OP) for detecting parvovirus B19-specific immunoglobulin G (IgG) was established. As antigens, B19-specific oligopeptides of 24 and 30 kDa derived from a 196-kDa fusion protein of beta-galactosidase and viral capsid protein (VPI) of B19 after CNBr cleavage and separation by high-pressure liquid chromatography were used. Of 139 serum specimens tested in parallel for anti-B19 IgG by standard ELISA using B19 particles as antigen and by ELISA B19-OP, 73 (52.5%) were positive and 63 (45.3%) were negative in both tests, and 3 (2.2%) were negative by standard ELISA but positive by ELISA B19-OP and by immunoblot. By using ELISA B19-OP, it was possible to detect anti-B19 IgG in an asymptomatic blood donor 4 weeks after acute infection, and anti-B19 IgG titers of 10(-5) could be measured in convalescent-phase sera.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=269794Documentos Relacionados
- Identification and mapping of neutralizing epitopes of human parvovirus B19 by using human antibodies.
- Human Parvovirus B19
- Human parvovirus B19 encephalopathy.
- Generation of Neutralizing Human Monoclonal Antibodies against Parvovirus B19 Proteins
- Evaluation of serological assays for identification of parvovirus B19 immunoglobulin M.
